[YTL] YoY TTM Result on 31-Mar-2008 [#3]

Stock
[YTL] YTL CORPORATION BHD
Announcement Date
22-May-2008
Admission Sponsor
-
Sponsor
-
Financial Year
30-Jun-2008
Quarter
31-Mar-2008 [#3]
Profit Trend
QoQ- 12.27%
YoY- 63.06%
Quarter Report
Latest QR
Upcoming QR
YTL's Result
YTL's Financial Summary
View:
Show?
TTM Result
31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 31/03/05 CAGR
Revenue 17,864,965 15,329,646 7,167,139 6,461,271 5,829,196 5,253,986 4,759,739 24.65%
PBT 2,321,974 2,399,660 2,030,823 1,867,792 1,442,686 1,452,436 1,269,695 10.57%
Tax -666,649 -1,009,843 -441,882 -141,876 -308,526 -433,492 -708,457 -1.00%
NP 1,655,325 1,389,817 1,588,941 1,725,916 1,134,160 1,018,944 561,238 19.74%
-
NP to SH 857,577 801,652 940,474 975,915 598,504 682,916 561,238 7.31%
-
Tax Rate 28.71% 42.08% 21.76% 7.60% 21.39% 29.85% 55.80% -
Total Cost 16,209,640 13,939,829 5,578,198 4,735,355 4,695,036 4,235,042 4,198,501 25.23%
-
Net Worth 8,967,097 10,127,859 7,980,380 7,324,927 6,865,703 5,763,852 4,506,100 12.14%
Dividend
31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 31/03/05 CAGR
Div 358 122,012 37,389 375,566 330,531 107,026 106,824 -61.29%
Div Payout % 0.04% 15.22% 3.98% 38.48% 55.23% 15.67% 19.03% -
Equity
31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 31/03/05 CAGR
Net Worth 8,967,097 10,127,859 7,980,380 7,324,927 6,865,703 5,763,852 4,506,100 12.14%
NOSH 1,793,419 1,795,719 1,523,147 1,502,425 1,502,868 1,440,963 1,380,883 4.45%
Ratio Analysis
31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 31/03/05 CAGR
NP Margin 9.27% 9.07% 22.17% 26.71% 19.46% 19.39% 11.79% -
ROE 9.56% 7.92% 11.78% 13.32% 8.72% 11.85% 12.46% -
Per Share
31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 31/03/05 CAGR
RPS 996.14 853.68 470.55 430.06 387.87 364.62 344.69 19.33%
EPS 47.82 44.64 61.75 64.96 39.82 47.39 40.64 2.74%
DPS 0.02 6.79 2.50 25.00 21.99 7.50 7.74 -62.93%
NAPS 5.00 5.64 5.2394 4.8754 4.5684 4.00 3.2632 7.36%
Adjusted Per Share Value based on latest NOSH - 1,502,425
31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 31/03/05 CAGR
RPS 160.96 138.11 64.57 58.21 52.52 47.34 42.88 24.65%
EPS 7.73 7.22 8.47 8.79 5.39 6.15 5.06 7.31%
DPS 0.00 1.10 0.34 3.38 2.98 0.96 0.96 -
NAPS 0.8079 0.9125 0.719 0.6599 0.6186 0.5193 0.406 12.14%
Price Multiplier on Financial Quarter End Date
31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 31/03/05 CAGR
Date 31/03/11 31/03/10 31/03/09 31/03/08 30/03/07 31/03/06 31/03/05 -
Price 1.39 1.41 1.30 1.39 1.28 0.96 1.06 -
P/RPS 0.14 0.17 0.28 0.32 0.33 0.26 0.31 -12.40%
P/EPS 2.91 3.16 2.11 2.14 3.21 2.03 2.61 1.82%
EY 34.40 31.66 47.50 46.73 31.11 49.37 38.34 -1.79%
DY 0.01 4.82 1.92 17.99 17.18 7.81 7.30 -66.65%
P/NAPS 0.28 0.25 0.25 0.29 0.28 0.24 0.32 -2.19%
Price Multiplier on Announcement Date
31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 31/03/05 CAGR
Date 26/05/11 27/05/10 21/05/09 22/05/08 24/05/07 18/05/06 27/05/05 -
Price 1.52 1.34 1.32 1.40 1.61 0.95 0.97 -
P/RPS 0.15 0.16 0.28 0.33 0.42 0.26 0.28 -9.87%
P/EPS 3.18 3.00 2.14 2.16 4.04 2.00 2.39 4.87%
EY 31.46 33.32 46.78 46.40 24.74 49.89 41.90 -4.66%
DY 0.01 5.07 1.89 17.86 13.66 7.89 7.98 -67.14%
P/NAPS 0.30 0.24 0.25 0.29 0.35 0.24 0.30 0.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment